摩根士丹利基金管理(中国)有限公司 |
Morgan Stanley Private Equity Asia is one of the leading private equity investors in the Asia-Pacific region. Established in 1993, we invest primarily in highly structured minority investments and control buyouts in growth-oriented companies.
Morgan Stanley Private Equity Asia specializes in privately negotiated minority investments in companies with substantial business operations in the Asia-Pacific region. We target fast growing businesses with strong brands, sustainable competitive advantages and proven track records of financial performance. On a selective basis, we also pursue control investments where we believe we can add significant value to the business. Our investment process is geared towards generating returns through intrinsic value creation, as opposed to employing excessive financial leverage or relying on continuously increasing public market values.
Our team invests across sectors, particularly in the areas of consumer products, industrial products, financial services, healthcare and telecom/technology. Companies based in China and Korea have received a significant percentage of the total dollars we have invested since 1993, but we actively seek geographic diversification within our portfolios and we have executed deals in most major countries in the region.
We take a hands-on approach to providing our portfolio companies with the assistance they need to continue to thrive within their markets. Our Investment Team devotes a significant amount of its time to working with management teams at the board level to advise, improve and support the execution of their business plans. Each Investment Team member leverages his or her skills to add value to portfolio companies by providing guidance on critical strategic and financing decisions, formulating and directing operating and growth strategies, raising and allocating capital and evaluating add-on acquisitions. The Investment Team also helps portfolio companies implement best practices by recruiting talented executives, designing appropriate incentive structures and establishing rigorous financial controls and governance systems. We believe that a proactive approach post-investment is a key driver of value creation, particularly in certain developing markets in Asia.
Since 1993, Morgan Stanley Private Equity Asia has been a major presence in the private equity market within the Asia-Pacific region. Our team consists of over 60 investment professionals who work from our offices in Hong Kong, Beijing, Shanghai, Seoul, Mumbai, and Bangkok. We have an established track record of working with portfolio companies to enhance their value as evidenced by our successful history of negotiating exits and generating returns for our Limited Partners.
We believe that our team’s association with Morgan Stanley, a leading global financial services firm with a significant presence in the region, provides our portfolio companies with unparalleled access to industry experts, managerial talent, intellectual capital and operational resources to help them execute their business strategies.
Reputation and relationships are what matter in Asia. We have over two decades of experience in the region, so we have a very strong reputation. We also have 60 investors in the region, so we have the right relationships. Finally, we have the Morgan Stanley name on our business cards which opens doors for us.
Reputation and relationships are what matter in Asia. We have over two decades of experience in the region, so we have a very strong reputation. We also have 60 investors in the region, so we have the right relationships. Finally, we have the Morgan Stanley name on our business cards which opens doors for us.
|
Fullife is a new-age consumer brand which manufactures and sells effervescent nutrition and wellness products in B2C and B2B segment.
Second largest specialized oncology player in India currently operating 14 hospitals with a total capacity of ~2,000 beds across 5 states in India
Largest urology-focused hospital chain in India operating 14 hospitals with 500+ beds across 7 cities
Maiva is India’s #2 largest pure-play injectables CDMO. It provides provides the full lifecycle of product development and manufacturing services to pharma marketers in regulated markets. It operates a USFDA approved plant with strong R&D capabilities and successful regulatory track record. It has a vast basket of approved products across therapy segments and covered in US shortage list
Founded in 2014, Skinidea is a leading supplier of Korean skincare products that operates its own brands, including Medipeel and Derma Maison. The company has a diversified product portfolio comprised of skincare products including cleansing foams, firming essences, soothing creams, anti-aging serums, and facial masks.
Oncology focused hospital chain with a capacity of 1,000 beds across 8 hospitals in India
Founded in 2004, Chenwei Zhongde is the largest private orthopedic hospital chain in China.
APAC Realty is Singapore’s leading real estate brokerage business
Established in 2017, Life & Bio Inc. is a leading health supplements company in Korea, supported by strong product development and marketing capabilities. The company also holds Foodcare, a subsidiary focused on ready-to-eat baby foods.
Pathology focused diagnostic chain having presence inWest and Central India through a network of labs and collection centres with capability to provide a wide range of testing services including specialized tests.
Founded in 2016, VSPN is one of the largest third party e-sports IP operator in China by market share. The company provides e-sports tournament operations services to top-tier gaming developers and publishers
Xing Han Bohner is one of a top pharma e-commerce player in China by GMV and revenue. It strategically focuses on the non-hospital channels and prescription drug distribution, and benefits from the outflow of medicine sales from hospital channels
Guodong Network is one of the largest independent telecommunications tower infrastructure service provider in China by number of telecom sites. The company rents land, constructs telecom towers, and then leases the tower space to telecommunications service providers
Ummeed is an affordable housing finance company (HFC) in India that provides secured retail loans to low-income group across home loans and business loans. These loans are typically collateralised against the self-occupied residential / commercial property of the borrower.
Company is present in 12 states in India as of Mar-25
Centrum is a housing finance company that provides secured retail home loans for home purchase and construction as well as loans against property in India.
Kogta Financial (India) Limited is a Western India-based Non-Banking Finance Company with more than 20 years of experience in the asset finance business. The company was incorporated in 1996 by Shri Banwari Lal Kogta, Shri Bal Mukund Kogta and Shri Radha Krishan Kogta and focuses on financing for a variety of commercial and private vehicles, Micro, Small and Medium Enterprises ("MSME") loans and Loans Against Property.
Founded in 1981 and headquartered in Taiwan, Microlife is one of the global leaders in developing, manufacturing and distributing consumer medical devices with leading market positions in its three core product categories, namely, blood pressure monitors (“BPM”), digital thermometers (“THM”) and flexible heating products (“FH”). The company is typically one of the top three market share leaders in the aforementioned product categories in the relevant regions.
Shenzhen ZTE Jinyun Technology Company Limited (“Golden Cloud Technology”) is a leading Internet Data Center (“IDC”) business with a portfolio of 11 IDC centers in premium locations across China, such as Beijing and Shenzhen, providing colocation and value added services, with a focus on financial services sector
Anhui One & Only is a leading medical beauty hospital chain offering a diversified portfolio of services with particular strength in its surgical procedures. The One & Only brand is well recognized by local customers as a symbol for quality, service and safety.
Nspira is one of the largest education services businesses in India, which caters to K-12 schools and also runs test-preparation tutorials for engineering and medical college entrance exams. Nspira services over 500 K-12 schools with a student base of over 335,000 across 13 states in India. The Company provides end-to-end solutions for all the schools it services, including all non-academic functions and curriculum design.
Established in May 2016 in Yancheng by Chairman Biqian Liu, Hyperon is one of the largest membrane producers for membrane bioreactors (“MBR”) in China by capacity. MBR are a key component used in wastewater treatment plants.
Established in 2003, Sino-Canada is an international school operator in Suzhou, China with over 2,500 students and 300 teachers currently. It has over 13 years of experience in offering bilingual K-12 education courses in China, covering pre-school, primary, secondary and high school courses.
Established in 1996, Korres is a top Greek natural skin care and cosmetics brand with a sizable market presence in Greece’s pharmacy industry, as well as a presence in Greece, the US, and certain EU countries. Korres has a portfolio of over 400 herbal products covering nine major categories in beauty and personal care.
Southern Health Foods is a packaged food products company, manufacturing and marketing natural health foods in India. The company has created a health food platform with an array of natural, preservative-free food products. Southern Health Foods offers its products under the brand “Manna”.
SMT is one of the leading domestic manufacturers of cardiac devices in India, and its product portfolio includes minimally invasive coronary stents, renal stents, PTCA balloon catheters and other cardiac/vascular accessories.
Founded in 2012 and headquartered in Shanghai, XChange engages in professional insurance agency business in China Formerly known as FLJ Group Limited/ Q&K International Group Limited , the company changed its name to XChange TEC.INC in May 2024.
Shanghai KNX is a human resources consulting and management training company.
ZCL Chemicals Limited is a specialized pharmaceutical company based in India that is engaged in the manufacturing and export of advanced drug intermediates and Active Pharma Ingredients.
Founded in 2005 and headquartered in Chengdu, China Showyu is a leading aesthetic services provider.
Founded in 2004 and headquartered in Shanghai, CDP is one of the leading private sector payroll and benefits HR outsourcing companies in China.
Founded in 2004 and headquartered in Beijing, Coinage is one of the leading financial education companies in China, with a dominant position in the financial planning certification market.
Headquartered in Shanghai, IVD Medical is one of the leading distribution groups of In-Vitro Diagnostic analyzers and reagents in China.
Five Star Business Finance is a non-banking financial company, providing secured loans against property to the low-income segment in India.
A leading branded diaper producer in China, focusing on the fast growing e-commerce sales channel.
Royal Dynasty is a leading branded franchise operator of hotpot and dessert restaurants in China. It is one of the largest restaurant networks in China with over 800 hotpot and dessert restaurants under the Huang Ji Huang and the Hui Lau Shan brands, covering mainland China, Hong Kong, Singapore, Australia, Indonesia and Canada.
Founded in 1988 and headquartered in Beijing, China Kang Fu is one of the pioneers of the Chinese financial leasing industry.
Founded in 1991, Omni Remotes develops, manufactures and sells remote control devices.
Renfang Medical is engaged in the investment in, and management of, general hospitals with leading positions in local markets and specialty hospitals in Tier 1 and Tier 2 cities in China.
Founded in 2004 and headquartered in Shanghai, Baijia is the second largest private sector maternity hospital chain in China by number of hospitals.
AMTD is a leading full-fledged securities service platform and cross-border investment bank in Asia as well as the largest local asset management and corporate insurance brokerage firm in Hong Kong.
Innocean Worldwide is one of the largest advertising agencies in Korea.
Noah Education, based in China, is a leading directly-owned-and-operated kindergarten operator by number of directly-owned kindergartens as of June 30, 2017.
Headquartered in Beijing, Wendu is the largest National Graduate Entrance Examination ("NGEE") training service provider in China by revenue.
Hanwha L&C is a leading building materials manufacturer in Korea and engages in the production and distribution of four main product segments within the industry: windows, flooring materials, decorative films & sheets and premium surfaces.
DSG (Cayman) Limited is one of the top independent producers of branded baby and adult diaper products in South East Asia, with leading market share in Thailand, Malaysia and Indonesia.
Founded in 2001, Sino Gas is engaged in the development and installation of natural gas distribution networks and the distribution of natural gas to residential and industrial customers in China.
Strategy Name | Description |
---|---|
Makes privately negotiated equity and equity-related investments in companies located in the Asia-Pacific region.
|
Makes privately negotiated equity and equity-related investments in companies located in the Asia-Pacific region. |
As of 3/9/2020. Team and portfolio information may change from time to time.
There is no guarantee that any of the investments listed above resulted in positive performance (for realized holdings), or will perform well in the future (for current holdings). The trademarks and service marks above are the property of their respective owners. The information on this website has not been authorized, sponsored, or otherwise approved by such owners.
By clicking on any links shown here, you agree that you are navigating to a third party site. We are providing these hyperlinks to you only as a convenience and the inclusion of any hyperlink is not and does not imply any endorsement, approval, investigation, verification or monitoring by us of any information contained in any hyperlinked site. In no event shall we be responsible for the information contained on the site or your use of such site.
The information presented herein is solely for informational and educational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.
The information presented does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision. There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market.
Diversification does not protect you against a loss in a particular market; however it allows you to spread that risk across various asset classes. Past performance is no guarantee of future results.
Leveraging Morgan Stanley Resources - Subject to third party confidentiality agreement obligations and information barriers established by Morgan Stanley to manage potential conflicts of interest and applicable allocation policies.
Alternative investments are speculative and include a high degree of risk. Investors could lose all or a substantial amount of their investment. Alternative investments are suitable only for long-term investors willing to forego liquidity and put capital at risk for an indefinite period of time. Alternative investments are typically highly illiquid – there is no secondary market for private funds, and there may be restrictions on redemptions or assigning or otherwise transferring investments into private funds. Alternative investment funds often engage in leverage and other speculative practices that may increase volatility and risk of loss. Alternative investments typically have higher fees and expenses than other investment vehicles, and such fees and expenses will lower returns achieved by investors.
In the ordinary course of its business, Morgan Stanley engages in a broad spectrum of activities including, among others, financial advisory services, investment banking, asset management activities and sponsoring and managing private investment funds. In engaging in these activities, the interest of Morgan Stanley may conflict with the interests of clients.
Alternative investment funds are often unregulated, are not subject to the same regulatory requirements as mutual funds, and are not required to provide periodic pricing or valuation information to investors. The investment strategies described in the preceding pages may not be suitable for your specific circumstances; accordingly, you should consult your own tax, legal or other advisors, at both the outset of any transaction and on an ongoing basis, to determine such suitability.
No investment should be made without proper consideration of the risks and advice from your tax, accounting, legal or other advisors as you deem appropriate.
Morgan Stanley is a full-service securities firm engaged in a wide range of financial services including, for example, securities trading and brokerage activities, investment banking, research and analysis, financing and financial advisory services. Morgan Stanley Investment Management is the asset management division of Morgan Stanley.
CRC# 1872443 Expiration Date: 10/1/2018